17th Jan 2008 18:08
GlaxoSmithKline PLC17 January 2008 This announcement replaces the original announcement released on 3 January 2008at 16:38, RNS No: 0587L. The number of dividends reinvested for Dr Ronaldo Schmitz should have read664.19, not 666.93 as previously stated, and the number of dividends reinvestedfor Mr Tom de Swaan should have read 35.15, not 34.26 as previously stated. All other details remain unchanged. The amended text appears below. Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons I give below details of changes in the directors' interests in the OrdinaryShares and American Depository Shares (ADSs) of GlaxoSmithKline plc. On 31 December 2007, the Company's Non-Executive Directors were provisionallyallocated the following awards over Ordinary Shares and American DepositoryShares (ADSs) in the Company through the Annual Re-investment of Dividends paidthroughout 2007: SmithKline Beecham Non-Executive Directors Retainer Fee and Share AllocationAward - Annual Dividend Reinvestment Non-Executive Director No. of Ordinary Average Price (£) Shares Sir Ian Prosser 42.361 12.8433 GlaxoSmithKline Non-Executive Directors Automatic Share Award and Elected ShareAward - Annual Dividend Reinvestment Non-Executive Director No. of Ordinary Average No. of ADSs Average Shares Price (£) Price ($)Sir Christopher Gent 728.17 12.8433Prof Sir Roy Anderson - -Dr Stephanie Burns 5.92 50.82Mr Lawrence Culp 357.82 50.82Sir Crispin Davis 729.43 12.8433Sir Deryck Maughan 278.73 50.82Dr Daniel Podolsky 43.48 50.82Sir Ian Prosser 767.65 12.8433Dr Ronaldo Schmitz 664.19 12.8433Mr Tom de Swaan 35.15 12.8433Sir Robert Wilson 191.97 12.8433 The Company and the Non-Executive Directors were informed of these allocationson 2 January 2008. This notification relates to transactions notified in accordance with Disclosureand Transparency Rule 3.1.4R(1)(a). S M BicknellCompany Secretary3 January 2008 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline